Cargando…
Emerging hiPSC Models for Drug Discovery in Neurodegenerative Diseases
Neurodegenerative diseases affect millions of people worldwide and are characterized by the chronic and progressive deterioration of neural function. Neurodegenerative diseases, such as Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), and Huntington’s disease...
Autores principales: | Trudler, Dorit, Ghatak, Swagata, Lipton, Stuart A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347370/ https://www.ncbi.nlm.nih.gov/pubmed/34360966 http://dx.doi.org/10.3390/ijms22158196 |
Ejemplares similares
-
Mechanisms of hyperexcitability in Alzheimer’s disease hiPSC-derived neurons and cerebral organoids vs isogenic controls
por: Ghatak, Swagata, et al.
Publicado: (2019) -
NitroSynapsin ameliorates hypersynchronous neural network activity in Alzheimer hiPSC models
por: Ghatak, Swagata, et al.
Publicado: (2021) -
hiPSC-Derived Cardiac Tissue for Disease Modeling and Drug Discovery
por: Li, Junjun, et al.
Publicado: (2020) -
hiPSC-Derived Cells as Models for Drug Discovery
por: Ofir, Rivka
Publicado: (2021) -
hiPSC-Derived Cells as Models for Drug Discovery 2.0
por: Ofir, Rivka
Publicado: (2023)